For help on how to get the results you want, see our search tips.
3 results
Medicine
Maximum residue limits Remove Maximum residue limits filter
Referrals Remove Referrals filter
Summaries of opinion Remove Summaries of opinion filter
Referral decision making model
PRAC-CMDh Remove PRAC-CMDh filter
Referral status
CMDh final position Remove CMDh final position filter
European Commission final decision Remove European Commission final decision filter
Referral type
Article 31 referrals Remove Article 31 referrals filter
Referral PRAC recommendation
Revocation Remove Revocation filter
-
List item
Referral: Amfepramone-containing medicinal products
amfepramone, associated names: Regenon, Tenuate Retard, Amfepramon-Hormosan, Regenon Retard, Article 31 referrals
Status: European Commission final decision, opinion/position date: 10/11/2022, EC decision date: 13/01/2023, Last updated: 20/01/2023 -
List item
Referral: Flupirtine-containing medicinal products
flupirtine, Article 31 referrals
Status: CMDh final position, opinion/position date: 21/03/2018, Last updated: 04/05/2018 -
List item
Referral: Fusafungine containing medicinal products for oromucosal and nasal use
fusafungine, Article 31 referrals
Status: CMDh final position, opinion/position date: 31/03/2016, Last updated: 14/04/2016